BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 333889)

  • 1. Effects of intravenous verapamil on hemodynamics in patients with heart disease.
    Singh BN; Roche AH
    Am Heart J; 1977 Nov; 94(5):593-9. PubMed ID: 333889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate haemodynamic effects of verapamil in man.
    Lewis BS; Mitha AS; Gotsman MS
    Cardiology; 1975; 60(6):366-76. PubMed ID: 1231967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of verapamil on myocardial performance in coronary disease.
    Ferlinz J; Easthope JL; Aronow WS
    Circulation; 1979 Feb; 59(2):313-9. PubMed ID: 365390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemodynamic effects of intravenous verapamil in patients on chronic propranolol therapy.
    Reddy PS; Uretsky BF; Steinfeld M
    Am Heart J; 1984 Jan; 107(1):97-101. PubMed ID: 6691247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of intravenous timolol in coronary artery disease.
    Chew CY; Collett J; Shah PK; Singh BN
    Clin Pharmacol Ther; 1979 Sep; 26(3):330-8. PubMed ID: 466927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hemodynamic effect of verapamil by intravenous administration in middle-aged, subjectively healthy subjects at rest and during exercise].
    Atterhög JH; Ekelund LG
    Minerva Med; 1975 May; 66(39):1877-82. PubMed ID: 1128828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of verapamil in left ventricular valvular volume overload.
    Butman SM; Eagan J; Olson HG
    Am Heart J; 1985 Aug; 110(2):416-26. PubMed ID: 4025117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure.
    Ferlinz J; Citron PD
    Am J Cardiol; 1983 May; 51(8):1339-45. PubMed ID: 6846161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of acute hemodynamic and electrophysiologic effects of verapamil in humans: role of myocardial drug uptake.
    Powell AC; Horowitz JD; Kertes PJ; Hasin Y; Syrjanen ML; Henry CA; Sartor DM; Louis WJ
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):572-83. PubMed ID: 1706798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
    Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of halothane anesthesia and verapamil on systemic hemodynamics and left ventricular myocardial contractility in patients with ischemic heart disease.
    Schulte-Sasse U; Hess W; Markschies-Hornung A; Tarnow J
    Anesth Analg; 1984 Sep; 63(9):791-8. PubMed ID: 6331775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of verapamil and practolol in man.
    Seabra-Gomes R; Rickards A; Sutton R
    Eur J Cardiol; 1976 Mar; 4(1):79-85. PubMed ID: 1261583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct cardiac and peripheral vascular effects of intracoronary and intravenous nifedipine.
    Terris S; Bourdillon PD; Cheng DT; Pitt B
    Am J Cardiol; 1986 Jul; 58(1):25-30. PubMed ID: 3728327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.
    Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD
    Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects caused by i.v. administration of verapamil in healthy subjects.
    Vincenzi M; Allegri P; Gabaldo S; Maiolino P; Ometto R
    Arzneimittelforschung; 1976; 26(6):1221-3. PubMed ID: 989421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
    Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.